Last reviewed · How we verify
NCT03550898
Can Dynamic Ultrasonography Replace Urodynamics in Follow-up of Patients With Myelomeningocele
NA trial testing Dynamic Ultrasonography in Neurogenic Bladder in 81 participants. Completed in 1 February 2017.
1 February 2017
Quick facts
| Lead sponsor | Hospital de Clinicas de Porto Alegre |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Primary purpose | diagnostic |
| Enrollment | 81 |
| Start date | 1 June 2014 |
| Primary completion | 1 February 2017 |
| Estimated completion | 1 February 2017 |
Drugs / interventions tested
- Dynamic Ultrasonography
Conditions studied
- Neurogenic Bladder — all drugs for Neurogenic Bladder →
- Myelomeningocele — all drugs for Myelomeningocele →
Sponsor
Hospital de Clinicas de Porto Alegre
Who can join
Eligibility, any sex, with Neurogenic Bladder or Myelomeningocele. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with neurogenic bladder need periodic evaluation with urodynamic study, a invasive and uncomfortable procedure. Aim: To evaluate the accuracy of dynamic ultrasonography as a feasible and noninvasive alternative diagnostic method to identify detrusor overactivity in patients with neurogenic bladder
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03550898
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neurogenic Bladder
Currently open trials in the same condition.
- NCT07308808 — Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation · EARLY_PHASE1 · recruiting
- NCT04187027 — Efficacy Of Pulsed Electromagnetic Field Therapy On Neurogenic Bladder in Children With Myelomeningocele · NA · active not recruiting
- NCT04791579 — Antibiotic Prophylaxis for Neurogenic Bladder Botox · Phase 2 · recruiting
- NCT06515223 — Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury · NA · recruiting
- NCT06163469 — Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healt · NA · recruiting
Other Hospital de Clinicas de Porto Alegre trials
Trials by the same sponsor.
- NCT07469722 — POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure · Phase 2, PHASE3 · not yet recruiting
- NCT07264179 — Tracheal Cuff Pressure and Postoperative Complications: A Prospective Observational Study. · not yet recruiting
- NCT07052058 — Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to · Phase 2 · not yet recruiting
- NCT06953128 — General Versus Regional Anesthesia in Peripheral Arterial Surgery · NA · not yet recruiting
- NCT06934707 — Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03550898 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital de Clinicas de Porto Alegre
- Last refreshed: 8 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03550898.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing